Species
|
Resource
|
RRC ID
|
Title
|
Journal
|
Published
|
Link
|
Human and Animal Cells
|
JHOC-5(RCB1520)
,
JHOC-9(RCB2226)
|
72538
|
MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma.
|
BMC Cancer |
2014-11-3 |
Pubmed
Full text
|
Human and Animal Cells
|
JHOC-5(RCB1520)
|
65432
|
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation.
|
BMC Cancer |
2014-2-22 |
Pubmed
Full text
|
Human and Animal Cells
|
TUHR4TKB(RCB1198)
,
TUHR10TKB(RCB1275)
,
TUHR14TKB(RCB1383)
|
62174
|
Hypermethylation of the RASSF1A tumor suppressor gene in Japanese clear cell renal cell carcinoma.
|
Oncol Rep |
2004-10-1 |
Pubmed
|
Human and Animal Cells
|
JHOC-5(RCB1520)
,
JHOC-7(RCB1688)
,
JHOC-8(RCB1723)
,
JHOC-9(RCB2226)
|
61806
|
Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis.
|
PLoS One |
2013-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
JHOC-7(RCB1688)
,
JHOC-9(RCB2226)
|
61799
|
MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.
|
Oncotarget |
2016-11-15 |
Pubmed
Full text
|
Human and Animal Cells
|
JHOC-5(RCB1520)
|
54755
|
PIK3CA hotspot mutations and cyclooxygenase-2 expression in ovarian clear cell carcinomas: a close association with stromal features.
|
Hum Pathol |
2019-4-1 |
Pubmed
Full text
|
Human and Animal Cells
|
JHOC-5(RCB1520)
|
53988
|
ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors.
|
Oncogene |
2018-8-1 |
Pubmed
Full text
|
Human and Animal Cells
|
JHOC-5(RCB1520)
,
JHOC-7(RCB1688)
,
JHOC-9(RCB2226)
|
51845
|
MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma.
|
PLoS One |
2016-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
|
44829
|
Epigenetic determinants of ovarian clear cell carcinoma biology.
|
Int J Cancer |
2014-8-1 |
Pubmed
Full text
|
Human and Animal Cells
|
JHOC-9(RCB2226)
,
JHOC-5(RCB1520)
|
43906
|
Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma.
|
Hum Pathol |
2012-12-1 |
Pubmed
Full text
|
Human and Animal Cells
|
JHOC-9(RCB2226)
|
38446
|
Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma.
|
Cancer |
2012-6-1 |
Pubmed
Full text
|
Human and Animal Cells
|
NIH:OVCAR-3(RCB2135)
|
18556
|
Wild-type p53 enhances annexin IV gene expression in ovarian clear cell adenocarcinoma.
|
FEBS J |
2011-5-1 |
Pubmed
Full text
|
Human and Animal Cells
|
OS-RC-2(RCB0735)
|
17644
|
Combined functional genome survey of therapeutic targets for clear cell carcinoma of the kidney.
|
Jpn J Clin Oncol |
2011-7-1 |
Pubmed
Full text
|